Skip to Content
Merck
CN
  • Functional assays with human patient-derived enteroid monolayers to assess the human gut barrier.

Functional assays with human patient-derived enteroid monolayers to assess the human gut barrier.

STAR protocols (2021-08-03)
Ibrahim M Sayed, Courtney Tindle, Ayden G Fonseca, Pradipta Ghosh, Soumita Das
ABSTRACT

Here, we describe the use of polarized patient enteroid-derived monolayers (EDMs) to assess the impact of e-cigarettes on the human gut barrier. These EDMs can be adapted to culture in a 96-well plate for high-throughput screening. We model the effect of e-cigarettes by combining pathogens, enteroids, and e-cigarette vapor-infused media and assess gut barrier integrity, bacterial internalization, and inflammatory response of the gut epithelium. This protocol can be used to assess the effects of e-cigarette components on gut functions. For complete details on the use and execution of this protocol, please refer to Sharma et al. (2021).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SB 202190, ≥98% (HPLC)
Sigma-Aldrich
N-Acetyl-L-cysteine, suitable for cell culture, BioReagent